Cattle producers and veterinarians now have a new management tool for added reproductive efficiency. Zoetis has announced the introduction of Lutalyse HighCon Injection (dinoprost tromethamine injection), a high-concentration formula of the proven Lutalyse Injection (dinoprost injection) approved for use in dairy and beef cattle.

The higher-concentration formula of Lutalyse HighCon allows for a 2-mL dose. This provides more doses per bottle, thus fewer bottle changes and a quicker, more convenient administration.

Flexibility with subcutaneous administration option

Lutalyse HighCon is the first and only prostaglandin on the market licensed by the U.S. Food and Drug Administration for subcutaneous administration in addition to intramuscular administration. This approval allows producers and veterinarians flexible administration options while allowing them to abide by strict Dairy Animal Care and Quality Assurance as well as Beef Quality Assurance (BQA) standards, in turn, minimizing potential injection site blemishes.

Larger bottle sizes

To fit varying herd management needs, this product is available in three bottle sizes – 20 mL, 100 mL and 250 mL. It’s important to note that this product is approved for use in cattle only, not equine or swine.

Approved for use with Factrel Injection for FTAI

Like Lutalyse, Lutalyse HighCon is approved for use with Factrel Injection (gonadorelin injection) to synchronize estrous cycles to allow for fixed-time artificial insemination (FTAI) in lactating dairy cows. FTAI with these products can help improve reproductive efficiency. It also gives producers the flexibility to implement many of the popular synchronization programs recommended by the Dairy Cattle Reproduction Council.


Learn more about this new product at the Zoetis website.  PD

—From Zoetis news release